reference/309585

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/309585

Outgoing Links

Predicate	Object
contentType	Journal Article\|Review
endingPage	291
issn	1083-7159 1549-490X
issueIdentifier	4
pageRange	282-291
publicationName	The Oncologist
startingPage	282
bibliographicCitation	Dubey S, Schiller JH. Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximab. Oncologist. 2005 Apr;10(4):282–91. doi: 10.1634/theoncologist.10-4-282. PMID: 15821248.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_237f5f211847831b67f9204ba82491fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d772929a6f7b963c59e1c5564633fc9
date	2005-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15821248 https://doi.org/10.1634/theoncologist.10-4-282
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21392 https://portal.issn.org/resource/ISSN/1083-7159 https://portal.issn.org/resource/ISSN/1549-490X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Three Emerging New Drugs for NSCLC: Pemetrexed, Bortezomib, and Cetuximab
discusses	http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0422675 http://id.nlm.nih.gov/mesh/M0002834 http://id.nlm.nih.gov/mesh/M0018225 http://id.nlm.nih.gov/mesh/M0350110 http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0227083
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D006147Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D000069286 http://id.nlm.nih.gov/mesh/D011719Q000008 http://id.nlm.nih.gov/mesh/D017322 http://id.nlm.nih.gov/mesh/D000964Q000627 http://id.nlm.nih.gov/mesh/D017321 http://id.nlm.nih.gov/mesh/D005971Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D006147Q000008 http://id.nlm.nih.gov/mesh/D001897Q000008 http://id.nlm.nih.gov/mesh/D000068818 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D008495Q000639
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413520 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.1.1.45 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135916113 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101068009 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135564751 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168322524 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136068113 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f0f123cab8e4c2e3a727eeea342293a http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.25.1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e108905ee2ef97a014793e952b01add6 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1044 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136253316 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243055978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128884697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127502201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128365023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700914

Total number of triples: 74.